Self-assembly of Bacitracin (cas 1405-87-4)-gold nanoparticles and their toxicity analysis

Add time:09/26/2019    Source:sciencedirect.com

As the widely use of gold nanoparticles (AuNPs) in drug delivery, the precise control on the size and morphology of the AuNPs is urgently required. In this scenario, traditional synthesis methods cannot meet current requirement because of their inherent defects. We have depicted here a novel method for fabricating monodispersed large size gold nanoparticles, based on the self-assembly of bacitracin. The AuNPs could be facilely, low-cost, and green synthesized with repeatability and controllability in this method. The Bac gold nanoparticles (Bac-AuNPs), composed by bacitracin core and gold shell, exhibited a spherical morphology in TEM and a face-centered cubic crystal structure in X-Ray diffraction and selected area electron diffraction. The mean diameter of the Bac-AuNPs was 89 nm. The nanoparticles were mono-dispersed and the zeta potential of the nanoparticles was 4.1 ± 0.64 mV. Notably, in cell viability assay, the Bac-AuNPs showed less toxicity to HepG2 cells and HEK293 cells compared to small size AuNPs. Collectively, the size, rheological characteristic and the biocompatibility supported the use of the gold nanoparticles as intracellular delivery vehicles for drug delivery, especially for tumor therapy. And this study could provide a maneuverable, controllable and green strategy for the synthesis of AuNPs, which would be applied in disease diagnosis and therapy with biosafety.

We also recommend Trading Suppliers and Manufacturers of Bacitracin (cas 1405-87-4). Pls Click Website Link as below: cas 1405-87-4 suppliers

Prev:Original ArticleUntangling the transcription regulatory network of the Bacitracin (cas 1405-87-4) synthase operon in Bacillus licheniformis DW2
Next:Bacitracin (cas 1405-87-4) promotes osteogenic differentiation of human bone marrow mesenchymal stem cells by stimulating the bone morphogenetic protein-2/Smad axis)